Nation’s largest Health Care and Life Sciences Practice adds six attorneys in
Washington, D.C., and Chicago to increase its capacity to service food, drug
and medical device companies; EBG also adds health care consultant to its D.C.
WASHINGTON, Feb. 8 – LAWFUEL – The Law News Network — As part of the continued expansion of the nation’s largest Health Care and Life Sciences Practice, Epstein Becker & Green, P.C. (EBG) today announced the addition of six food, drug and medical device regulatory attorneys and a health care consultant to its Washington, D.C. and Chicago offices.
With these additions, EBG is now home to more than 115 health care and
life sciences attorneys nationally, including 62 in Washington, D.C., where
health care issues will likely be a centerpiece of the hotly contested 2006
elections. EBG’s added capacity also coincides with the emergence of the
medical device field as one of the most profitable, and promising segments of
the U.S. economy.
Joining EBG in Washington, D.C., as members of the firm, are attorneys
Brad Thompson and Ted Mannen, along with health care consultant Paul Campbell
and associate Leah R. Kendall. They come from the Washington, D.C. office of
Baker & Daniels LLP. Joining EBG in Chicago, as a member of the firm, is Karen
Weaver. Ms. Weaver comes from The Weaver Law Group, LLC, along with associates
Christina G. Kolliniatis and James M. Lancheros.
“These additions to our Health Care and Life Sciences Practice strengthen
Epstein Becker’s ability to serve our clients, particularly in areas related
to food, drug and medical device law,” said Doug Hastings, chair of Epstein
Becker & Green’s Health Care and Life Sciences Practice. Hastings added, “It
is our goal to provide a breadth and depth of expertise to clients in the
health and life sciences-related industries that is unmatched among law firms
of any size. These key additions — focused on FDA/FTC regulatory matters, as
well as coding, coverage and payment matters — are another step in
solidifying our leadership in this area.”
Lynn Shapiro Snyder, head of the Third Party Payment Practice Group within
EBG’s Health Care and Life Sciences Practice, said: “While addressing FDA
issues is important for drug and device manufacturers wanting to do business
in the US, we also are adding more resources to our existing health regulatory
practice that addresses Medicare, Medicaid and other third party payment
coding, coverage and payment issues for drug and device manufacturers that are
located throughout the world seeking to do business in the complex health care
system in the United States.”
In Washington, D.C., Bradley M. Thompson joins as member of the firm with
broad experience representing food, drug and medical device companies with
respect to the regulatory requirements of the U.S. Food and Drug
Administration, the Centers for Medicare and Medicaid Services, and other
federal and state agencies. Mr. Thompson has received several honors,
including being named as one of the 100 notable people in the Medical Device
Industry by Medical Device & Diagnostic Industry in 2004. Thompson frequently
writes on the medical device industry and product development. He holds
positions on several boards at various organizations, including the Indiana
Medical Device Manufactures Council and the Combination Product Coalition.
Mr. Thompson received his J.D. from Michigan Law School, and his M.B.A and his
B.A. at the University of Illinois.
Also in Washington, D.C., Ted Mannen brings nearly 25 years of experience
in law and public policy to EBG. At the Health Industry Manufacturers
Association (HIMA, now AdvaMed — the Advanced Medical Technology
Association), an international trade association that represents manufacturers
of medical devices and diagnostic products, Mannen held several positions
including General Counsel & Secretary, Senior Vice President, Policy &
Communications and Executive Vice President of Health Care Systems. As
General Counsel, Mannen helped HIMA address a range of issues before the Food
& Drug Administration and was responsible for product liability matters. Mr.
Mannen received his J.D. from Northwestern University School of Law and his
B.A. from Southern Illinois University.
Brad and Ted are joined by associate Leah R. Kendall, who received her
B.S. from Butler University and graduated first in her class from Indiana
University School of Law.
Karen Weaver, who joins EBG’s Chicago office, is an attorney and a
pharmacist. Karen and her colleagues advise clients on regulatory compliance,
advertising, and multi-level marketing matters. They represent clients before
federal and state administration and judicial bodies, and are also involved in
intellectual property and commercial litigation on the advertising side. At
EBG, Weaver will assist clients with FDA, FTC and other federal and state
regulatory bodies. She frequently speaks and writes on topics such as
labeling and advertising of food. Ms. Weaver received her J.D. from DePaul
University College of Law and her B.S. from the University of Toledo.
Ms. Weaver is joined by two associates, Christina G. Kolliniatis and James
M. Lancheros. They previously worked with Ms. Weaver at Weaver Law. Ms.
Kolliniatis received her J.D. from California Western School of Law and her
B.S. from the University of Illinois. Mr. Lancheros received his J.D. from
DePaul University College of Law and his B.S. from Indiana University.
Also joining EBG in Washington, D.C. as a non-attorney consultant, is Paul
Campbell, a health care strategist experienced in research, consulting, and
management. He provides strategic reimbursement advisory services to health
care provider systems as well as to companies and trade groups in the
diagnostics, medical device, pharmaceutical and life sciences industry.
About Epstein Becker & Green, P.C.
Epstein Becker & Green, P.C., founded in 1973, is a law firm with over 380
attorneys practicing in 11 offices throughout the United States – Atlanta,
Chicago, Dallas, Houston, Los Angeles, Miami, New York, Newark, San Francisco,
Stamford, and Washington, D.C. – and affiliations worldwide. The firm’s size,
diversity, and global affiliations allow its attorneys to address the needs of
small entrepreneurial ventures, middle market companies, and large
multinational corporations on a worldwide basis. EBG was recognized by Modern
Healthcare Magazine in 2005 as the nation’s largest health care law firm.
EBG continues to build and expand its capabilities as a law firm focused
on five core practices: Commercial Litigation, Corporate and Securities,
Health Care & Life Sciences, Labor & Employment, and Real Estate. For more
information about EBG, please visit the firm’s web site at http://www.ebglaw.com.